Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.800
0.00 (0.00%)
Dec 5, 2025, 4:00 PM EST - Market closed
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $268.21 million as of December 5, 2025. Its market cap has increased by 8,340.67% in one year.
Market Cap
268.21M
Enterprise Value
263.19M
1-Year Change
8,340.67%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $268.21M, an increase of 257.28%. That is a compound annual growth rate of 31.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 268.21M | 5,776.72% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |